59 related articles for article (PubMed ID: 9369304)
1. Reduction in the ratio of beta-preprotachykinin to preproenkephalin messenger RNA expression in postmortem human putamen during aging and in patients with status lacunaris. Implications for the susceptibility to parkinsonism.
Tohgi H; Utsugisawa K; Yoshimura M; Yamagata M; Nagane Y; Saitoh K
Brain Res; 1997 Sep; 768(1-2):86-90. PubMed ID: 9369304
[TBL] [Abstract][Full Text] [Related]
2. Alterations with aging and ischemia in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human putamen. Implications for susceptibility to parkinsonism.
Tohgi H; Utsugisawa K; Yoshimura M; Nagane Y; Mihara M
Brain Res; 1998 Apr; 791(1-2):186-90. PubMed ID: 9593888
[TBL] [Abstract][Full Text] [Related]
3. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
[TBL] [Abstract][Full Text] [Related]
4. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Nisbet AP; Foster OJ; Kingsbury A; Eve DJ; Daniel SE; Marsden CD; Lees AJ
Neuroscience; 1995 May; 66(2):361-76. PubMed ID: 7477878
[TBL] [Abstract][Full Text] [Related]
5. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients.
Richfield EK; Maguire-Zeiss KA; Vonkeman HE; Voorn P
Ann Neurol; 1995 Dec; 38(6):852-61. PubMed ID: 8526457
[TBL] [Abstract][Full Text] [Related]
6. Thalamo-striatal deafferentation affects preproenkephalin but not preprotachykinin gene expression in the rat striatum.
Salin P; Kachidian P
Brain Res Mol Brain Res; 1998 Jun; 57(2):257-65. PubMed ID: 9675424
[TBL] [Abstract][Full Text] [Related]
7. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
Mijnster MJ; Schotte A; Docter GJ; Voorn P
Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839
[TBL] [Abstract][Full Text] [Related]
8. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
Zeng BY; Jenner P; Marsden CD
Mov Disord; 1996 Jan; 11(1):43-52. PubMed ID: 8771066
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents.
Campbell K; Wictorin K; Björklund A
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes in D1 and D2 receptor mRNA expression in postmortem human putamen with and without multiple small infarcts.
Tohgi H; Utsugisawa K; Yoshimura M; Nagane Y; Mihara M
Neurosci Lett; 1998 Feb; 243(1-3):37-40. PubMed ID: 9535107
[TBL] [Abstract][Full Text] [Related]
11. Alterations in prodynorphin, proenkephalin, and GAD67 mRNA levels in the aged human putamen: correlation with Parkinson's disease.
Bäckman CM; Shan L; Zhang Y; Hoffer BJ; Tomac AC
J Neurosci Res; 2007 Mar; 85(4):798-804. PubMed ID: 17203488
[TBL] [Abstract][Full Text] [Related]
12. Chronic naltrexone treatment increases expression of preproenkephalin and preprotachykinin mRNA in discrete brain regions.
Tempel A; Kessler JA; Zukin RS
J Neurosci; 1990 Mar; 10(3):741-7. PubMed ID: 2319301
[TBL] [Abstract][Full Text] [Related]
13. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
Calon F; Birdi S; Rajput AH; Hornykiewicz O; Bédard PJ; Di Paolo T
J Neuropathol Exp Neurol; 2002 Feb; 61(2):186-96. PubMed ID: 11853020
[TBL] [Abstract][Full Text] [Related]
14. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
15. Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain.
Chesselet MF; Affolter HU
Brain Res; 1987 Apr; 410(1):83-8. PubMed ID: 3580901
[TBL] [Abstract][Full Text] [Related]
16. Changes with aging and ischemia in nicotinic acetylcholine receptor subunit alpha7 mRNA expression in postmortem human frontal cortex and putamen.
Utsugisawa K; Nagane Y; Tohgi H; Yoshimura M; Ohba H; Genda Y
Neurosci Lett; 1999 Aug; 270(3):145-8. PubMed ID: 10462115
[TBL] [Abstract][Full Text] [Related]
17. Comparison of basal and D-1 dopamine receptor agonist-stimulated neuropeptide gene expression in caudate-putamen and nucleus accumbens of ad libitum fed and food-restricted rats.
Haberny SL; Carr KD
Brain Res Mol Brain Res; 2005 Nov; 141(2):121-7. PubMed ID: 16257473
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of tachykinin vs. enkephalin gene expression in the posterior striatum in response to acute p-chloroamphetamine treatment during postnatal development.
Basura GJ; Walker PD
Brain Res Dev Brain Res; 1999 Jan; 112(1):155-7. PubMed ID: 9974171
[TBL] [Abstract][Full Text] [Related]
19. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
[TBL] [Abstract][Full Text] [Related]
20. Normalization of striatal proenkephalin and preprotachykinin mRNA expression by fetal substantia nigra grafts.
Mendez IM; Naus CC; Elisevich K; Flumerfelt BA
Exp Neurol; 1993 Jan; 119(1):1-10. PubMed ID: 8432341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
